These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 25498887

  • 21. Predictive value of primary tumor volume change during concurrent chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer.
    In Lee H, Kyung Choi E, Ssan Kim S, Seob Shin Y, Won Park J, Yeol Song S.
    Radiother Oncol; 2024 Sep; 198():110383. PubMed ID: 38879129
    [Abstract] [Full Text] [Related]

  • 22. Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy.
    Ahn SY, Park CM, Park SJ, Kim HJ, Song C, Lee SM, McAdams HP, Goo JM.
    Invest Radiol; 2015 Oct; 50(10):719-25. PubMed ID: 26020832
    [Abstract] [Full Text] [Related]

  • 23. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ, Koshy M, Liptay MJ, Fidler MJ.
    Cancer; 2014 Jul 01; 120(13):2060-8. PubMed ID: 24692108
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: retrospective analysis of 425 patients.
    Topkan E, Parlak C, Selek U.
    Int J Radiat Oncol Biol Phys; 2013 Nov 15; 87(4):697-704. PubMed ID: 24035331
    [Abstract] [Full Text] [Related]

  • 26. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1438-43. PubMed ID: 16029805
    [Abstract] [Full Text] [Related]

  • 27. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
    Arslan D, Tural D, Koca T, Tastekin D, Kaymak Cerkesli A, Basaran H, Gunduz S, Murat Tatli A, Sezgin Goksu S, Uysal M, Kargi A, Kargi B, Koral L, Ibrahim Bassorgun C, Unal D, Mutlu H, Senol Coskun H, Ozdogan M, Bozcuk H.
    J BUON; 2015 Aug 01; 20(2):573-9. PubMed ID: 26011352
    [Abstract] [Full Text] [Related]

  • 28. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
    Wink KC, Belderbos JS, Dieleman EM, Rossi M, Rasch CR, Damhuis RA, Houben RM, Troost EG.
    Radiother Oncol; 2016 Mar 01; 118(3):453-9. PubMed ID: 26861738
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Correlation of Ktrans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy.
    Wang D, Liu S, Fu J, Zhang P, Zheng S, Qiu B, Liu H, Ye Y, Guo J, Zhou Y, Jiang H, Yin S, He H, Xie C, Liu H.
    J Immunother Cancer; 2024 Jun 23; 12(6):. PubMed ID: 38910009
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy.
    Oh D, Ahn YC, Park HC, Lim DH, Noh JM, Cho WK, Pyo H.
    Oncotarget; 2017 May 30; 8(22):35700-35706. PubMed ID: 28415687
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ.
    J Natl Cancer Inst; 2011 Dec 07; 103(23):1761-70. PubMed ID: 22056739
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
    Roengvoraphoj O, Wijaya C, Eze C, Li M, Dantes M, Taugner J, Tufman A, Huber RM, Belka C, Manapov F.
    Strahlenther Onkol; 2018 Feb 07; 194(2):107-115. PubMed ID: 29116336
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.